Federal contract award
75N91021P00495
RNASCOPE TECHNOLOGY IS REQUIRED FOR US TO RELIABLY IDENTIFY THE SOURCE OF THE TGFBETA ISOFORMS THAT ARE SIGNALING IN NORMAL TISSUES AND TUMORS. NO OTHER TECHNOLOGY ENABLES US TO DO THIS ON SAMPLES WITH MINIMAL MATERIAL (EG HEART VALVES). THE INFORMAT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $11.6K |
| Current contract value | $11.6K |
| Potential contract value / ceiling | $11.6K |
| Start date | May 28, 2021 |
| Current end date | Jun 27, 2021 |
| Potential end date | Jun 27, 2021 |
| Latest award activity | May 28, 2021 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 28, 2021 | 0 | $11.6K | RNASCOPE TECHNOLOGY IS REQUIRED FOR US TO RELIABLY IDENTIFY THE SOURCE OF THE TGFBETA ISOFORMS THAT ARE SIGNALING IN NORMAL TISSUES AND TUMORS. NO OTHER TECHNOLOGY ENABLES US TO DO THIS ON SAMPLES WITH MINIMAL MATERIAL (EG HEART VALVES). THE INFORMAT |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.